Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07480018 · ClinicalTrials.gov registry record · NA
Berberine Supplementation, Sprint Interval Training, and Immune Function Study
A NA study of Well-being and Inflammation Biomarkers, sponsored by University of Northern Colorado.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07480018: Recruiting NA study of Well-being and Inflammation Biomarkers, sponsored by University of Northern Colorado.
NCT07480018 is a NA study of Well-being and Inflammation Biomarkers that is actively recruiting participants, run by University of Northern Colorado. The registered enrollment target is 40 participants, below the 1,271-participant average among 11 other Well-being trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07480018, a NA study of Well-being and Inflammation Biomarkers, is actively recruiting participants, sponsored by University of Northern Colorado.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencing mild mental health challenges. The main questions it aims to answer are: * Does short-term berberine use or sprint training improve measures of mental health, psychological wellbeing, fatigue, and sleep quality? * Does short-term berberine use or sprint training improve measures of anaerobic power generation? * Does short-term berberine use or sprint training improve circulating biomarkers of inflammation? * Does short-term berberine use or sprint training improve monocyte number, function, and cytokine production?
Primary Outcome
Whole blood single cell suspension, 200 μL, will be stained for CD14 (anti-human CD14-FITC) and CD16 (anti-human CD16-APC) (BioLegend, San Diego CA) following lysis of red blood cells with 1X Red Blood Cell Lysis Buffer (BioLegend, San Diego CA) and blocking of Fc receptors with Fc-Blocker (BioLegend, San Diego CA). Prepared samples will be run on an Attune NxT flow cytometer (Thermo Fisher Scientific, Waltham, MA) following fixation and permeabilization.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Berberine
- OTHER Sprint Interval Training
Study Locations (1)
Colorado
- University of Northern Colorado - Greeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT07480018 shows while recruiting
NCT07480018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,271-participant average among 11 other Well-being trials with a reported enrollment target (97% lower).
The record links to 6 conditions, with Well-being appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT07480018 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07480018 about?
NCT07480018 is a clinical study titled "Berberine Supplementation, Sprint Interval Training, and Immune Function Study". The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencin...
What is the current status of trial NCT07480018?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-01. Estimated completion is 2026-06-01.
What conditions does trial NCT07480018 study?
This clinical trial studies the following conditions: Well-being, Inflammation Biomarkers, Berberine, Sprint Training, Anaerobic Power.
What interventions are being tested in trial NCT07480018?
The interventions under investigation include: Placebo (OTHER), Berberine (DIETARY_SUPPLEMENT), Sprint Interval Training (OTHER).
Who is sponsoring clinical trial NCT07480018?
This trial is sponsored by University of Northern Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07480018 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Well-being
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07480018's enrollment target sits among peer trials
40 10th of 11 higher than 1 of 11 other Well-being trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Well-being trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Addressing the Mental Health and Emotional Well-being of Immigrants Through a Scalable Intervention
RECRUITING · NA
-
Health and Wellness Coaching to Improve Thoracic Transplant Caregiver Self-Efficacy
RECRUITING · NA
-
Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention
RECRUITING · NA
-
The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program
RECRUITING · NA
-
A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID
ACTIVE NOT RECRUITING · NA
-
Rise & Renew: Supporting Well-Being in Black Women After the Loss of a Loved One
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI